126 related articles for article (PubMed ID: 18242077)
1. Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States.
Sant M; Allemani C; De Angelis R; Carbone A; de Sanjosè S; Gianni AM; Giraldo P; Marchesi F; Marcos-Gragera R; Martos-Jiménez C; Maynadié M; Raphael M; Berrino F;
Eur J Cancer; 2008 Mar; 44(4):579-87. PubMed ID: 18242077
[TBL] [Abstract][Full Text] [Related]
2. Differences in non-Hodgkin lymphoma survival between young adults and children.
Tai E; Pollack LA; Townsend J; Li J; Steele CB; Richardson LC
Arch Pediatr Adolesc Med; 2010 Mar; 164(3):218-24. PubMed ID: 20194253
[TBL] [Abstract][Full Text] [Related]
3. Childhood cancer survival trends in Europe: a EUROCARE Working Group study.
Gatta G; Capocaccia R; Stiller C; Kaatsch P; Berrino F; Terenziani M;
J Clin Oncol; 2005 Jun; 23(16):3742-51. PubMed ID: 15923571
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups.
Allemani C; Sant M; De Angelis R; Marcos-Gragera R; Coebergh JW;
Cancer; 2006 Jul; 107(2):352-60. PubMed ID: 16770772
[TBL] [Abstract][Full Text] [Related]
5. Childhood cancer survival in Europe and the United States.
Gatta G; Capocaccia R; Coleman MP; Ries LA; Berrino F
Cancer; 2002 Oct; 95(8):1767-72. PubMed ID: 12365026
[TBL] [Abstract][Full Text] [Related]
6. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
[TBL] [Abstract][Full Text] [Related]
7. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
8. Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000).
Goubin A; Auclerc MF; Auvrignon A; Patte C; Bergeron C; Hémon D; Clavel J
Eur J Cancer; 2006 Mar; 42(4):534-41. PubMed ID: 16412629
[TBL] [Abstract][Full Text] [Related]
9. Incidence of uveal melanoma in Europe.
Virgili G; Gatta G; Ciccolallo L; Capocaccia R; Biggeri A; Crocetti E; Lutz JM; Paci E;
Ophthalmology; 2007 Dec; 114(12):2309-15. PubMed ID: 17498805
[TBL] [Abstract][Full Text] [Related]
10. Toward a comparison of survival in American and European cancer patients.
Gatta G; Capocaccia R; Coleman MP; Gloeckler Ries LA; Hakulinen T; Micheli A; Sant M; Verdecchia A; Berrino F
Cancer; 2000 Aug; 89(4):893-900. PubMed ID: 10951355
[TBL] [Abstract][Full Text] [Related]
11. Expected long-term survival of older patients diagnosed with non-Hodgkin lymphoma in 2008-2012.
Pulte D; Gondos A; Brenner H
Cancer Epidemiol; 2012 Feb; 36(1):e19-25. PubMed ID: 21959230
[TBL] [Abstract][Full Text] [Related]
12. Trends in cervical cancer survival in Europe, 1983-1994: a population-based study.
Bielska-Lasota M; Inghelmann R; van de Poll-Franse L; Capocaccia R;
Gynecol Oncol; 2007 Jun; 105(3):609-19. PubMed ID: 17399766
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
[TBL] [Abstract][Full Text] [Related]
14. Secondary non-Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL.
Landmann E; Oschlies I; Zimmermann M; Moser O; Graf N; Suttorp M; Greiner J; Reiter A;
Br J Haematol; 2008 Nov; 143(3):387-94. PubMed ID: 18729852
[TBL] [Abstract][Full Text] [Related]
15. Ongoing improvement in outcomes for patients diagnosed as having Non-Hodgkin lymphoma from the 1990s to the early 21st century.
Pulte D; Gondos A; Brenner H
Arch Intern Med; 2008 Mar; 168(5):469-76. PubMed ID: 18332290
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin lymphoma in Romania: a single-centre experience.
Fetica B; Achimas-Cadariu P; Pop B; Dima D; Petrov L; Perry AM; Nathwani BN; Müller-Hermelink HK; Diebold J; MacLennan KA; Fulop A; Blaga ML; Coza D; Nicula FA; Irimie A; Weisenburger DD
Hematol Oncol; 2017 Jun; 35(2):198-205. PubMed ID: 26482423
[TBL] [Abstract][Full Text] [Related]
17. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I;
Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993
[TBL] [Abstract][Full Text] [Related]
18. Survival of European children and young adults with cancer diagnosed 1995-2002.
Gatta G; Zigon G; Capocaccia R; Coebergh JW; Desandes E; Kaatsch P; Pastore G; Peris-Bonet R; Stiller CA;
Eur J Cancer; 2009 Apr; 45(6):992-1005. PubMed ID: 19231160
[TBL] [Abstract][Full Text] [Related]
19. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A
Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin's lymphoma incidence and survival in European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project.
Izarzugaza MI; Steliarova-Foucher E; Martos MC; Zivkovic S
Eur J Cancer; 2006 Sep; 42(13):2050-63. PubMed ID: 16919770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
